• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

118.30 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 172
Open 118.30
Bid (Size) 118.00 (100)
Ask (Size) 119.00 (2,000)
Prev. Close 118.30
Today's Range 118.30 - 118.30
52wk Range 88.57 - 128.70
Shares Outstanding 1,253,809,440
Dividend Yield 2.67%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
U.S. Scales Back The Number Of Vaccines It Recommends For Every Child ↗
January 05, 2026
Move comes in response to a presidential memorandum issued by President Donald Trump in December, aimed at aligning U.S. vaccination practices with other developed nations. 
Via Stocktwits
Topics Government
News headline image
3 Cash-Flow Machines Investors May Want Heading Into 2026 ↗
January 02, 2026
Via MarketBeat

Performance

YTD
-2.7%
-2.7%
1 Month
-2.4%
-2.4%
3 Month
+4.2%
+4.2%
6 Month
+5.8%
+5.8%
1 Year
+29.7%
+29.7%

More News

Read More
News headline image
Here's How Much $1000 Invested In Gilead Sciences 15 Years Ago Would Be Worth Today ↗
January 01, 2026
Via Benzinga
News headline image
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
Assembly Biosciences Stock Jumps After Wall Street Says Gilead Opt-In ‘Significantly De-Risks’ Genital Herpes Programs ↗
December 22, 2025
Via Stocktwits
News headline image
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via MarketMinute
Topics Artificial Intelligence ETFs Economy
News headline image
What's Driving the Market Sentiment Around Gilead Sciences Inc? ↗
December 31, 2025
Via Benzinga
News headline image
Stock Index Futures Slip in Weak End to a Banner Year
December 31, 2025
Via Barchart.com
Topics Bonds Government Stocks
News headline image
Discover which S&P500 stocks are making waves on Tuesday. ↗
December 30, 2025
Via Chartmill
News headline image
GILEAD SCIENCES INC (NASDAQ:GILD) Shows High Technical and Setup Ratings for a Potential Breakout ↗
December 27, 2025
Via Chartmill
News headline image
Jobless Claims Unexpectedly Fall For Second Consecutive Week ↗
December 24, 2025
Via Stocktwits
Topics Stocks
News headline image
Repare Therapeutics Stock Rises As Gilead Secures Cancer Asset For $30 Million ↗
December 24, 2025
Via Benzinga
News headline image
RPTX Stock Soars Pre-Market After Gilead Agrees To Acquire Investigational Cancer Drug ↗
December 24, 2025
Via Stocktwits
Fitch Sees Stable 2026 Outlook For Global Pharma — But Warns Trump Drug Pricing Push Poses Profit Risk ↗
December 23, 2025
Via Stocktwits
Topics Government
News headline image
These S&P500 stocks are moving in today's session ↗
December 23, 2025
Via Chartmill
News headline image
Gilead Sciences to Present at Upcoming Investor Conference
December 22, 2025
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Gilead Sciences Bets On Weekly Pill To Tackle Genital Herpes ↗
December 22, 2025
Via Benzinga
News headline image
Gilead Sciences Exercises Option to License Assembly Biosciences’ Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
December 22, 2025
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Trump Secures Drug Price Cuts From 9 Major Pharma Firms Including Bristol Myers, Gilead, Merck In Medicaid Deal ↗
December 20, 2025
Via Benzinga
Topics Government
News headline image
Why Gilead Sciences (GILD) Stock Is Up Today
December 19, 2025
Via StockStory
Topics Earnings
News headline image
Trump Strikes New Drug-Price Deals With Roche, Novartis, Merck And Other Pharma Giants ↗
December 19, 2025
Via Stocktwits
Topics Government World Trade
News headline image
Dow Jones' Merck, Other Drugmakers Strike Drug-Pricing Bargains With Trump ↗
December 19, 2025
Via Investor's Business Daily
Topics Government Stocks
News headline image
Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans
December 19, 2025
From Gilead Sciences, Inc.
Via Business Wire
News headline image
Gilead Sciences Inc. (NASDAQ:GILD): A High-Quality Dividend Stock for Reliable Income ↗
December 19, 2025
Via Chartmill
News headline image
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗
December 19, 2025
Via Stocktwits
Topics Economy Government

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 118.30
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 01/05/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 148.33B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 148B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap